Journal of Microbiology

Journal Article

Furan-based Chalcone Annihilates the Multi-Drug-Resistant Pseudomonas aeruginosa and Protects Zebra Fish Against its Infection: Santosh Pushpa Ramya Ranjan Nayak , Catharine Basty , Seenivasan Boopathi , Loganathan Sumathi Dhivya , Khaloud Mohammed Alarjani , Mohamed Ragab Abdel Gawwad , Raghda Hager , Muthu Kumaradoss Kathiravan , Jesu Arockiaraj; J. Microbiol. 2024;62(2):75-89. Published online February 21, 2024; DOI: https://doi.org/10.1007/s12275-024-00103-6

64 View
0 Download
8 Web of Science
9 Crossref

The emergence of carbapenem-resistant Pseudomonas aeruginosa, a multi-drug-resistant bacteria, is becoming a serious public health concern. This bacterium infects immunocompromised patients and has a high fatality rate. Both naturally and synthetically produced chalcones are known to have a wide array of biological activities. The antibacterial properties of synthetically produced chalcone were studied against P. aeruginosa. In vitro, study of the compound (chalcone derivative named DKO1), also known as (2E)-1-(5-methylfuran-2-yl)-3-(4-nitrophenyl) prop-2-en-1-one, had substantial antibacterial and biofilm disruptive action. DKO1 effectively shielded against P. aeruginosa-induced inflammation, oxidative stress, lipid peroxidation, and apoptosis in zebrafish larvae. In adult zebrafish, the treatment enhanced the chances of survivability and reduced the sickness-like behaviors. Gene expression, biochemical analysis, and histopathology studies found that proinflammatory cytokines (TNF-α, IL-1β, IL-6, iNOS) were down regulated; antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT) levels increased, and histoarchitecture was restored in zebrafish. The data indicate that DKO1 is an effective antibacterial agent against P. aeruginosa demonstrated both in vitro and in vivo.

Citations

Citations to this article as recorded by

Chalcone derivative enhance poultry meat preservation through quorum sensing inhibition against Salmonella (Salmonella enterica serovar Typhi) contamination
S.P. Ramya Ranjan Nayak, Pratik Pohokar, Anamika Das, L.S. Dhivya, Mukesh Pasupuleti, Ilavenil Soundharrajan, Bader O. Almutairi, Kathiravan Muthu Kumaradoss, Jesu Arockiaraj
Food Control.2025; 171: 111155. CrossRef
Harnessing Cyclic di-GMP Signaling: A Strategic Approach to Combat Bacterial Biofilm-Associated Chronic Infections
P. Snega Priya, Ramu Meenatchi, Mukesh Pasupuleti, S. Karthick Raja Namasivayam, Jesu Arockiaraj
Current Microbiology.2025;[Epub] CrossRef
Targeted inhibition of PqsR in Pseudomonas aeruginosa PAO1 quorum-sensing network by chalcones as promising antibacterial compounds
Negin Arami, Amineh Sadat Tajani, Maryam Hashemi, Tahoura Rezaei, Razieh Ghodsi, Vahid Soheili, Bibi Sedigheh Fazly Bazzaz
Molecular Biology Reports.2025;[Epub] CrossRef
Exposure to bisphenol A and sodium nitrate found in processed meat induces endocrine disruption and dyslipidemia through PI3K/AKT/SREBP pathway in zebrafish larvae
S. P. Ramya Ranjan Nayak, Anamika Das, Karthikeyan Ramamurthy, Mukesh Pasupuleti, Rajakrishnan Rajagopal, Jesu Arockiaraj
The Journal of Nutritional Biochemistry.2025; : 109887. CrossRef
Testing of Anti-EMT, Anti-Inflammatory and Antibacterial Activities of 2′,4′-Dimethoxychalcone
Peiling Zhao, Mengzhen Xu, Kai Gong, Kaihui Lu, Chen Ruan, Xin Yu, Jiang Zhu, Haixing Guan, Qingjun Zhu
Pharmaceuticals.2024; 17(5): 653. CrossRef
Furan-based chalcone protects β-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing Peroxisome Proliferator-Activated Receptor agonists (PPAR-γ) signaling
S.P. Ramya Ranjan Nayak, B. Haridevamuthu, Raghul Murugan, L.S. Dhivya, S. Venkatesan, Mikhlid H. Almutairi, Bader O. Almutairi, M.K. Kathiravan, S. Karthick Raja Namasivayam, Jesu Arockiaraj
Process Biochemistry.2024; 142: 149. CrossRef
Protective role of 2-aminothiazole derivative against ethanol-induced teratogenic effects in-vivo zebrafish
S. Madesh, Gokul Sudhakaran, Karthikeyan Ramamurthy, Avra Sau, Kathiravan Muthu Kumaradoss, Mikhlid H. Almutairi, Bader O. Almutairi, Senthilkumar Palaniappan, Jesu Arockiaraj
Biochemical Pharmacology.2024; 230: 116601. CrossRef
Tissue damage alleviation and mucin inhibition by P5 in a respiratory infection mouse model with multidrug-resistant Acinetobacter baumannii
Jun Hee Oh, Jonggwan Park, Hee Kyoung Kang, Hee Joo Park, Yoonkyung Park
Biomedicine & Pharmacotherapy.2024; 181: 117724. CrossRef
Toxicity and therapeutic property of dioxopiperidin derivative SKT40 demonstrated in-vivo zebrafish model due to inflammatory bowel disease
B. Aswinanand, S.P. Ramya Ranjan Nayak, S. Madesh, Suthi Subbarayudu, S. Kaliraj, Rajakrishnan Rajagopal, Ahmed Alfarhan, Muthu Kumaradoss Kathiravan, Jesu Arockiaraj
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology.2024; 284: 109990. CrossRef

Review

Current status and perspectives on vaccine development against dengue virus infection: Jisang Park , Ju Kim , Yong-Suk Jang; J. Microbiol. 2022;60(3):247-254. Published online February 14, 2022; DOI: https://doi.org/10.1007/s12275-022-1625-y

135 View
0 Download
29 Web of Science
28 Crossref

Abstract

Dengue virus (DENV) consists of four serotypes in the family Flaviviridae and is a causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. DENV is transmitted by mosquitoes, Aedes aegypti and A. albopictus, and is mainly observed in areas where vector mosquitoes live. The number of dengue cases reported by the World Health Organization increased more than 8-fold over the last two decades from 505,430 in 2000 to over 2.4 million in 2010 to 5.2 million in 2019. Although vaccine is the most effective
method
against DENV, only one commercialized vaccine exists, and it cannot be administered to children under 9 years of age. Currently, many researchers are working to resolve the various problems hindering the development of effective dengue vaccines; understanding of the viral antigen configuration would provide insight into the development of effective vaccines against DENV infection. In this review, the current status and perspectives on effective vaccine development for DENV are examined. In addition, a plausible direction for effective vaccine development against DENV is suggested.

Citations

Citations to this article as recorded by

Stochastic Runge–Kutta for numerical treatment of dengue epidemic model with Brownian uncertainty
Nabeela Anwar, Iftikhar Ahmad, Hijab Javaid, Adiqa Kausar Kiani, Muhammad Shoaib, Muhammad Asif Zahoor Raja
Modern Physics Letters B.2025;[Epub] CrossRef
Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
Supaluk Krittanai, Kaewta Rattanapisit, Christine Joy I. Bulaon, Pannamthip Pitaksajjakul, Sujitra Keadsanti, Pongrama Ramasoota, Richard Strasser, Waranyoo Phoolcharoen
Biotechnology Reports.2024; 42: e00844. CrossRef
In silico strategies for predicting therapeutic peptides targeting the capsid protein of the dengue virus
Neeraj Kumar Dixit, Ajay Kumar
Journal of Proteins and Proteomics.2024; 15(4): 675. CrossRef
Epidemiologic and clinical updates on viral infections in Saudi Arabia
Noura M. Alshiban, Munirah S. Aleyiydi, Majed S. Nassar, Nada K. Alhumaid, Thamer A. Almangour, Yahya M.K. Tawfik, Laila A. Damiati, Abdulaziz S. Almutairi, Essam A. Tawfik
Saudi Pharmaceutical Journal.2024; 32(7): 102126. CrossRef
“Seven-Plus-One Model”: A Move Toward Dengue Free Community
Santosh Kumar, Rakhi Mishra, Dharnidhar Singh
Indian Journal of Community Medicine.2024; 49(2): 249. CrossRef
Dengue fever: a decade of burden in Iran
Zahra Heydarifard, Fatemeh Heydarifard, Fatemeh Sadat Mousavi, Milad Zandi
Frontiers in Public Health.2024;[Epub] CrossRef
All-Atom Perspective of the DENV-3 Methyltransferase Inhibition Mechanism
Xiao Liu, Kaiwen Pang, Hangfei Wu, Xiaohui Wang, John Z. H. Zhang, Zhaoxi Sun
The Journal of Physical Chemistry B.2024; 128(50): 12358. CrossRef
Using UAV images and deep learning in investigating potential breeding sites of Aedes albopictus
Keyi Yu, Jianping Wu, Minghao Wang, Yizhou Cai, Minhui Zhu, Shenjun Yao, Yibin Zhou
Acta Tropica.2024; 255: 107234. CrossRef
Dengue
Gabriela Paz-Bailey, Laura E Adams, Jacqueline Deen, Kathryn B Anderson, Leah C Katzelnick
The Lancet.2024; 403(10427): 667. CrossRef
Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) as a Novel Score in Early Detection of Complicated Dengue Fever
Zubia Jamil, Samreen Khalid, Hafiz Muhammad Khan, Ikram Waheed, Amna Ehsan, Mohammed Alissa, Khalid Muhammad, Nayla Munawar, Yasir Waheed
Journal of Multidisciplinary Healthcare.2024; Volume 17: 2321. CrossRef
Dengue Virus 2 NS2B Targets MAVS and IKKε to Evade the Antiviral Innate Immune Response
Ying Nie, Dongqing Deng, Lumin Mou, Qizhou Long, Jinzhi Chen, Jiahong Wu
Journal of Microbiology and Biotechnology.2023; 33(5): 600. CrossRef
Deep learning approach for detection of Dengue fever from the microscopic images of blood smear
Hilda Mayrose, Niranjana Sampathila, G Muralidhar Bairy, Tushar Nayak, Sushma Belurkar, Kavitha Saravu
Journal of Physics: Conference Series.2023; 2571(1): 012005. CrossRef
Analysis of the correlation between climatic variables and Dengue cases in the city of Alagoinhas/BA
Marcos Batista Figueredo, Roberto Luiz Souza Monteiro, Alexandre do Nascimento Silva, José Roberto de Araújo Fontoura, Andreia Rita da Silva, Carolina Aparecida Pereira Alves
Scientific Reports.2023;[Epub] CrossRef
Dengue overview: An updated systemic review
Muhammad Bilal Khan, Zih-Syuan Yang, Chih-Yen Lin, Ming-Cheng Hsu, Aspiro Nayim Urbina, Wanchai Assavalapsakul, Wen-Hung Wang, Yen-Hsu Chen, Sheng-Fan Wang
Journal of Infection and Public Health.2023; 16(10): 1625. CrossRef
Applying a multi-strain dengue model to epidemics data
Robert G.S. de Araújo, Daniel C.P. Jorge, Rejane C. Dorn, Gustavo Cruz-Pacheco, M. Lourdes M. Esteva, Suani T.R. Pinho
Mathematical Biosciences.2023; 360: 109013. CrossRef
Impact of bound ssRNA length on allostery in the Dengue Virus NS3 helicase
Fernando Amrein, Carolina Sarto, Leila A Cababie, F Luis Gonzalez Flecha, Sergio B Kaufman, Mehrnoosh Arrar
Nucleic Acids Research.2023; 51(20): 11213. CrossRef
A novel colorimetric biosensor for rapid detection of dengue virus upon acid-induced aggregation of colloidal gold
Vo Thi Cam Duyen, Vo Van Toi, Truong Van Hoi, Phuoc Long Truong
Analytical Methods.2023; 15(32): 3991. CrossRef
Aromatic Residues on the Side Surface of Cry4Ba-Domain II of Bacillus thuringiensis subsp. israelensis Function in Binding to Their Counterpart Residues on the Aedes aegypti Alkaline Phosphatase Receptor
Anon Thammasittirong, Sutticha Na-Ranong Thammasittirong
Toxins.2023; 15(2): 114. CrossRef
Recombinant Protein Mimicking the Antigenic Structure of the Viral Surface Envelope Protein Reinforces Induction of an Antigen-Specific and Virus-Neutralizing Immune Response Against Dengue Virus
Ju Kim, Tae Young Lim, Jisang Park, Yong-Suk Jang
Journal of Microbiology.2023; 61(1): 131. CrossRef
Prevalence of dengue fever in Saudi Arabia: Jeddah as a case study
Hanan S. Alyahya
Entomological Research.2023; 53(12): 539. CrossRef
Biological Functions and Utilization of Different Part of the Papaya: A Review
Mingyue Jiao, Chao Liu, M.A. Prieto, Xiaoming Lu, Wenfu Wu, Jinyue Sun, P. García-Oliveira, Xiaozhen Tang, Jianbo Xiao, Jesus Simal-Gandara, Dagang Hu, Ningyang Li
Food Reviews International.2023; 39(9): 6781. CrossRef
Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement
Li-Chen Yen, Hsin-Wei Chen, Chia-Lo Ho, Chang-Chi Lin, Yi-Ling Lin, Qiao-Wen Yang, Kuo-Chou Chiu, Shu-Pei Lien, Ren-Jye Lin, Ching-Len Liao
Journal of Biomedical Science.2023;[Epub] CrossRef
Dengue hemorrhagic fever: a growing global menace
Shakeela Parveen, Zainab Riaz, Saba Saeed, Urwah Ishaque, Mehwish Sultana, Zunaira Faiz, Zainab Shafqat, Saman Shabbir, Sana Ashraf, Amna Marium
Journal of Water and Health.2023; 21(11): 1632. CrossRef
Exploring the inhibitory potential of Nigella sativa against dengue virus NS2B/NS3 protease and NS5 polymerase using computational approaches
Mamuna Mukhtar, Haris Ahmed Khan, Najam us Sahar Sadaf Zaidi
RSC Advances.2023; 13(27): 18306. CrossRef
Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors
Alexis A. Hatton, Fermin E. Guerra
Viruses.2022; 15(1): 52. CrossRef
Two years of COVID-19 pandemic: where are we now?
Jinjong Myoung
Journal of Microbiology.2022; 60(3): 235. CrossRef
Predictors of complicated dengue infections in endemic region of Pakistan
Ikram Waheed, Samreen Khalid, Zubia Jamil
Asian Pacific Journal of Tropical Medicine.2022; 15(11): 496. CrossRef
Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches
Mamuna Mukhtar, Amtul Wadood Wajeeha, Najam us Sahar Sadaf Zaidi, Naseeha Bibi
International Journal of Molecular Sciences.2022; 23(22): 13911. CrossRef

Journal Article

Potent antibacterial and antibiofilm activities of TICbf-14, a peptide with increased stability against trypsin: Liping Wang , Xiaoyun Liu , Xinyue Ye , Chenyu Zhou , Wenxuan Zhao , Changlin Zhou , Lingman Ma; J. Microbiol. 2022;60(1):89-99. Published online December 29, 2021; DOI: https://doi.org/10.1007/s12275-022-1368-9

65 View
0 Download
2 Web of Science
2 Crossref

Abstract

The poor stability of peptides against trypsin largely limits their development as potential antibacterial agents. Here, to obtain a peptide with increased trypsin stability and potent antibacterial activity, TICbf-14 derived from the cationic peptide Cbf-14 was designed by the addition of disulfide-bridged hendecapeptide (CWTKSIPPKPC) loop. Subsequently, the trypsin stability and antimicrobial and antibiofilm activities of this peptide were evaluated. The possible mechanisms underlying its mode of action were also clarified. The results showed that TICbf-14 exhibited elevated trypsin inhibitory activity and effectively mitigated lung histopathological damage in bacteria-infected mice by reducing the bacterial counts, further inhibiting the systemic dissemination of bacteria and host inflammation. Additionally, TICbf-14 significantly repressed bacterial swimming motility and notably inhibited biofilm formation. Considering the mode of action, we observed that TICbf-14 exhibited a potent membrane-disruptive mechanism, which was attributable to its destructive effect on ionic bridges between divalent cations and LPS of the bacterial membrane. Overall, TICbf-14, a bifunctional peptide with both antimicrobial and trypsin inhibitory activity, is highly likely to become an ideal candidate for drug development against bacteria.

Citations

Citations to this article as recorded by

Modified polymeric biomaterials with antimicrobial and immunomodulating properties
Katarzyna Szałapata, Mateusz Pięt, Martyna Kasela, Marcin Grąz, Justyna Kapral-Piotrowska, Aleksandra Mordzińska-Rak, Elżbieta Samorek, Paulina Pieniądz, Jolanta Polak, Monika Osińska-Jaroszuk, Roman Paduch, Bożena Pawlikowska-Pawlęga, Anna Malm, Anna Jar
Scientific Reports.2024;[Epub] CrossRef
Epinecidin-1, a marine antifungal peptide, inhibits Botrytis cinerea and delays gray mold in postharvest peaches
Li Fan, Yingying Wei, Yi Chen, Shu Jiang, Feng Xu, Chundan Zhang, Hongfei Wang, Xingfeng Shao
Food Chemistry.2023; 403: 134419. CrossRef

Reviews

MINIREVIEW] Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development: Hansong Chae , Sung Jae Shin; J. Microbiol. 2018;56(5):300-311. Published online May 2, 2018; DOI: https://doi.org/10.1007/s12275-018-8041-3

50 View
0 Download
19 Crossref

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a serious global health problem in the 21st century because of its high mortality. Mtb is an extremely successful human-adapted pathogen that displays a multifactorial ability to control the host immune response and to evade killing by drugs, resulting in the breakdown of BCG vaccine-conferred anti-TB immunity and development of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb. Although genetic components of the genomes of the Mtb complex strains are highly conserved, showing over 99% similarity to other bacterial genera, recently accumulated evidence suggests that the genetic diversity of the Mtb complex strains has implications for treatment outcomes, development of MDR/XDR Mtb, BCG vaccine efficacy, transmissibility, and epidemiological outbreaks. Thus, new insights into the pathophysiological features of the Mtb complex strains are required for development of novel vaccines and for control of MDR/XDR Mtb infection, eventually leading to refinement of treatment regimens and the health care system. Many studies have focused on the differential identification of Mtb complex strains belonging to different lineages because of differences in their virulence and geographical dominance. In this review, we discuss the impact of differing genetic characteristics among Mtb complex strains on vaccine efficacy, treatment outcome, development of MDR/ XDR Mtb strains, and epidemiological outbreaks by focusing on the best-adapted human Mtb lineages. We further explore the rationale for differential identification of Mtb strains for more effective control of TB in clinical and laboratory settings by scrutinizing current diagnostic methods.

Citations

Citations to this article as recorded by

Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review
Haiyang Zhang, Yi Liao, Zhensheng Zhu, Hanmin Liu, Deyuan Li, Sisi Wang
Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification
Haiyang Zhang, Maoting Tang, Deyuan Li, Min Xu, Yusen Ao, Liangkang Lin
Frontiers in Public Health.2024;[Epub] CrossRef
Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosis
Meg L. Donovan, Helle Bielefeldt‐Ohmann, Rachel F. Rollo, Stephen J. McPherson, Thomas E. Schultz, Giorgia Mori, Jessica C. Kling, Antje Blumenthal
Immunology.2023; 169(1): 13. CrossRef
Host vs. pathogen evolutionary arms race: Effects of exposure history on individual response to a genetically diverse pathogen
Daniel P. Walsh, Brandi L. Felts, E. Frances Cassirer, Thomas E. Besser, Jonathan A. Jenks
Frontiers in Ecology and Evolution.2023;[Epub] CrossRef
Antimycobacterial Activity of Hedeoma drummondii against Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria
Carmen Molina-Torres, Carlos Pedraza-Rodríguez, Lucio Vera-Cabrera, Jorge Ocampo-Candiani, Catalina Rivas-Morales, Ezequiel Viveros-Valdez
Antibiotics.2023; 12(5): 833. CrossRef
Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
Anabel Ordaz-Vázquez, Pedro Torres-González, Leticia Ferreyra-Reyes, Sergio Canizales-Quintero, Guadalupe Delgado-Sánchez, Lourdes García-García, Alfredo Ponce-De-León, José Sifuentes-Osornio, Miriam Bobadilla-Del-Valle
BMC Infectious Diseases.2023;[Epub] CrossRef
Will we ever eradicate animal tuberculosis?
Christian Gortázar, José de la Fuente, Alberto Perelló, Lucas Domínguez
Irish Veterinary Journal.2023;[Epub] CrossRef
Predominance of the Mycobacterium tuberculosis Beijing strain amongst children from a high tuberculosis burden township in South Africa
Junaid Shaik, Manormoney Pillay, Julie Moodley, Prakash Jeena
Tuberculosis.2022; 136: 102250. CrossRef
Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima—Peru
Kattya Lopez, María B. Arriaga, Juan G. Aliaga, Nadia N. Barreda, Oswaldo M. Sanabria, Chuan-Chin Huang, Zibiao Zhang, Ruth García-de-la-Guarda, Leonid Lecca, Anna Cristina Calçada Carvalho, Afrânio L. Kritski, Roger I. Calderon, Igor Mokrousov
PLOS ONE.2021; 16(1): e0243184. CrossRef
In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients
Ruoyan Ying, Xiaochen Huang, Yaxian Gao, Jie Wang, Yidian Liu, Wei Sha, Hua Yang
Infection and Drug Resistance.2021; Volume 14: 3729. CrossRef
Characterisation of secretome-based immune responses of human leukocytes infected with variousMycobacterium tuberculosislineages
Benjawan Kaewseekhao, Sittiruk Roytrakul, Yodying Yingchutrakul, Marut Laohaviroj, Kanin Salao, Kiatichai Faksri
PeerJ.2021; 9: e11565. CrossRef
Different PPD-stimulated cytokine responses from patients infected with genetically distinct Mycobacterium tuberculosis complex lineages
Paulo Ranaivomanana, Marie Sylvianne Rabodoarivelo, Mame Diarra Bousso Ndiaye, Niaina Rakotosamimanana, Voahangy Rasolofo
International Journal of Infectious Diseases.2021; 104: 725. CrossRef
A review of published spoligotype data indicates the diversity of Mycobacterium tuberculosis from India is under-represented in global databases
Husain Poonawala, Narender Kumar, Sharon J. Peacock
Infection, Genetics and Evolution.2020; 78: 104072. CrossRef
Comparing IS6110‐RFLP, PGRS‐RFLP and IS6110‐Mtb1/Mtb2 PCR methods for genotyping ofMycobacterium tuberculosisisolates
Kh. Ansarin, L. Sahebi, Y. Aftabi, M. Khalili, M. Seyyedi
Journal of Applied Microbiology.2020; 129(4): 1062. CrossRef
Molecular Typing of Mycobacterium Tuberculosis Isolated from Iranian Patients Using Highly Abundant Polymorphic GC-Rich-Repetitive Sequence
Bahram Golestani Eimani, Khalil Ansarin, Leila Sahebi, Maryam Seyyedi
Iranian South Medical Journal.2020; 23(2): 87. CrossRef
Comparison of the Three Molecular Diagnostic Assays for Molecular Identification ofMycobacterium tuberculosisand Nontuberculous Mycobacteria Species in Sputum Samples
Jinyoung Bae, Sung-Bae Park, Ji-Hoi Kim, Mi Ran Kang, Kyung Eun Lee, Sunghyun Kim, Hyunwoo Jin
Biomedical Science Letters.2020; 26(3): 170. CrossRef
Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent Mycobacterium tuberculosis Beijing K Strain
Woo Sik Kim, Hongmin Kim, Kee Woong Kwon, Sang-Nae Cho, Sung Jae Shin
Frontiers in Microbiology.2019;[Epub] CrossRef
Molecular characterisation of multidrug-resistantMycobacterium tuberculosisisolates from a high-burden tuberculosis state in Brazil
R. S. Salvato, S. Schiefelbein, R. B. Barcellos, B. M. Praetzel, I. S. Anusca, L. S. Esteves, M. L. Halon, G. Unis, C.F. Dias, S. S. Miranda, I. N. de Almeida, L. J. de Assis Figueredo, E. C. Silva, A. L. Kritski, E. R. Dalla Costa, M. L. R. Rossetti
Epidemiology and Infection.2019;[Epub] CrossRef
DNA markers for tuberculosis diagnosis
Kai Ling Chin, Maria E. Sarmiento, Mohd Nor Norazmi, Armando Acosta
Tuberculosis.2018; 113: 139. CrossRef

MINIREVIEW] Cure of tuberculosis using nanotechnology: An overview: Rout George Kerry , Sushanto Gouda , Bikram Sil , Gitishree Das , Han-Seung Shin , Gajanan Ghodake , Jayanta Kumar Patra; J. Microbiol. 2018;56(5):287-299. Published online May 2, 2018; DOI: https://doi.org/10.1007/s12275-018-7414-y

47 View
0 Download
8 Crossref

Abstract

Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), a major health issue of the present era. The bacterium inhabits the host macrophage and other immune cells where it modulates the lysosome trafficking protein, hinders the formation of phagolysosome, and blocks the TNF receptor- dependent apoptosis of host macrophage/monocytes. Other limitations such as resistance to and low bioavailability and bio-distribution of conventional drugs aid to their high virulence and human mortality. This review highlights the use of nanotechnology-based approaches for drug formulation and delivery which could open new avenues to limit the pathogenicity of tuberculosis. Moreover phytochemicals, such as alkaloids, phenols, saponins, steroids, tannins, and terpenoids, extracted from terrestrial plants and mangroves seem promising against M. tuberculosis through different molecular mechanisms. Further understanding of the genomics and proteomics of this pathogenic microbe could also help overcome various research gaps in the path of developing a suitable therapy against tuberculosis.

Citations

Citations to this article as recorded by

Multi-purpose prototypes for extrapulmonary Mycobacterium tuberculosis targeting: A regenerative medicine perspective
Mashudu T. Mphaphuli, Mduduzi N. Sithole, Pradeep Kumar, Pierre P.D. Kondiah, Mostafa Mabrouk, Yahya E. Choonara
Journal of Drug Delivery Science and Technology.2023; 89: 105039. CrossRef
Clay minerals-based drug delivery systems for anti-tuberculosis drugs
Saeida Saadat, Deepak Rawtani, Garvita Parikh
Journal of Drug Delivery Science and Technology.2022; 76: 103755. CrossRef
A Systematic Review on Antituberculosis Drug Discovery and Antimycobacterial Potential of Biologically Synthesized Silver Nanoparticles: Overview and Future Perspectives
Christian K. Ezeh, Chibuzor N. Eze, Uju M. E. Dibua, Stephen C. Emencheta
Infectious Microbes and Diseases.2022; 4(4): 139. CrossRef
Treatment of Tuberculosis in Nano Era: Recent Avenues
Ritu Rathi, Manju Nagpal, Malkiet Kaur, Priyansh Ballouria, Redhima Dutta, Geeta Aggarwal, Sandeep Arora
Current Bioactive Compounds.2022;[Epub] CrossRef
Detection of Mycobacterium Tuberculosis by Magnetic Nanoparticle Capture-Polymerase Chain Reaction
Zhanying Li, Lei Zhao, Lili Diao, Pei Wang, Conglu Che, Yanqing Tian, Xiuzheng Wang
Science of Advanced Materials.2021; 13(11): 2116. CrossRef
Inhalable linezolid loaded PLGA nanoparticles for treatment of tuberculosis: Design, development and in vitro evaluation
Sunny Shah, Dhanya Cristopher, Shweta Sharma, Moinuddin Soniwala, Jayant Chavda
Journal of Drug Delivery Science and Technology.2020; 60: 102013. CrossRef
Enhancement of cell proliferation and motility of mammalian cells grown in co-culture with Pichia pastoris expressing recombinant human FGF-2
Henry Hieu M. Le, David Vang, Nadia Amer, Tou Vue, Colwin Yee, Hyam Kaou, Joseph S. Harrison, Nan Xiao, Joan Lin-Cereghino, Geoff P. Lin-Cereghino, Der Thor
Protein Expression and Purification.2020; 176: 105724. CrossRef
Silver Nanoparticles for the Therapy of Tuberculosis

Alexandru-Flaviu Tăbăran, Cristian Tudor Matea, Teodora Mocan, Alexandra Tăbăran, Marian Mihaiu, Cornel Iancu, Lucian Mocan
International Journal of Nanomedicine.2020; Volume 15: 2231. CrossRef

Journal Articles

Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis: Ji-Chan Jang , Yong-Gyun Jung , Jungil Choi , Hyunju Jung , Sungweon Ryoo; J. Microbiol. 2017;55(6):483-487. Published online April 20, 2017; DOI: https://doi.org/10.1007/s12275-017-6630-1

45 View
0 Download
6 Crossref

Abstract

This study aimed to provide information that bedaquilline is significantly effective for treatment of totally drug resistant (TDR) Mycobacterium tuberculosis that shows resistant to all first- and second-line drugs-using an innovative disc agarose channel (DAC) system. Time-lapse images of single bacterial cells under culture conditions with different concentrations of bedaquiline were analysed by image processing software to determine minimum inhibitory concentrations (MICs). Bedaquiline inhibited the growth of TDR M. tuberculosis strains, with MIC values ranging from 0.125 to 0.5 mg/L. The results of the present study demonstrate that bedaquiline, newly approved by the United States Food and Drug Admi-nistration (FDA), may offer therapeutic solutions for TDR -TB.

Citations

Citations to this article as recorded by

Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
Rong Yao, Bin Wang, Lei Fu, Lei Li, Kejun You, Yong-Guo Li, Yu Lu, Luiz Pedro Sorio de Carvalho
Microbiology Spectrum.2022;[Epub] CrossRef
Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis
Nitin Verma, Vimal Arora, Rajendra Awasthi, Yinghan Chan, Niraj Kumar Jha, Komal Thapa, Talha Jawaid, Mehnaz Kamal, Gaurav Gupta, Gang Liu, Keshav Raj Paudel, Philip Michael Hansbro, Brian Gregory George Oliver, Sachin Kumar Singh, Dinesh Kumar Chellappan
Journal of Drug Delivery Science and Technology.2022; 75: 103690. CrossRef
In vitro activity of bedaquiline against Mycobacterium avium complex
Vitaly Litvinov, Marina Makarova, Dmitry Kudlay, Nikolai Nikolenko, Julia Mikhailova
Journal of Medical Microbiology .2021;[Epub] CrossRef
Problems of drug resistance of M. tuberculosis
V. I. Litvinov, E. Yu. Nosova
Tuberculosis and socially significant diseases.2021; 9(2): 70. CrossRef
Bedaquiline and linezolid MIC distributions and epidemiological cut-off values forMycobacterium tuberculosisin the Latin American region
Beatriz Lopez, Rosangela Siqueira de Oliveira, Juliana M W Pinhata, Erica Chimara, Edson Pacheco Ascencio, Zully M Puyén Guerra, Ingrid Wainmayer, Norberto Simboli, Mirtha Del Granado, Juan Carlos Palomino, Viviana Ritacco, Anandi Martin
Journal of Antimicrobial Chemotherapy.2019; 74(2): 373. CrossRef
Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon
Zubair Shanib Bhat, Muzafar Ahmad Rather, Mubashir Maqbool, Zahoor Ahmad
Biomedicine & Pharmacotherapy.2018; 103: 1733. CrossRef

Performance of nested multiplex PCR assay targeting MTP40 and IS6110 gene sequences for the diagnosis of tubercular lymphadenitis: Pallavi Sinha , Pradyot Prakash , Shashikant C.U. Patne , Shampa Anupurba , Sweety Gupta , G. N. Srivastava; J. Microbiol. 2017;55(1):63-67. Published online December 30, 2016; DOI: https://doi.org/10.1007/s12275-017-6127-y

44 View
0 Download
5 Crossref

Abstract

The conventional methods for diagnosis of tubercular lymphadenitis (TBLN) such as - fine needle aspiration cytology, Ziehl-Neelsen staining and culture have limitations of low sensitivity and/or specificity. So, it becomes essential to develop a rapid, sensitive, and specific method for an early diagnosis of TBLN. Therefore, the present study was conducted to evaluate nested multiplex polymerase chain reaction (nMPCR) targeting MTP40 and IS6110 gene sequences of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex, respectively in 48 successive patients of TBLN and 20 random patients with non-tubercular lymph node lesions. Out of the 48 cases of TBLN, 14 (29.2%) were found to be positive by Ziehl-Neelsen staining, 15 (31.2%) were positive by culture and 43 (89.6%) cases were positive after first round of PCR while 48 (100%) cases were positive by nMPCR assay. The sensitivity and specificity of nMPCR was found to be 100% for the diagnosis of TBLN. The results thus obtained indicate that nMPCR assay is a highly sensitive and specific tool for the diagnosis of TBLN.

Citations

Citations to this article as recorded by

Diagnosis of tuberculous lymphadenitis by molecular and immunological tools
Nitin Kumar, Anish Khan, Sanjit Boora, Neha Chadha, Nisha Khan, Puneet Raina, Rajesh Gupta, Raj Singh, Samander Kaushik
Medicine in Microecology.2024; 22: 100116. CrossRef
Evaluating the Sensitivity of Different Molecular Techniques for Detecting Mycobacterium tuberculosis Complex in Patients with Pulmonary Infection
Hassan A. Hemeg, Hamzah O. Albulushi, Hani A. Ozbak, Hamza M. Ali, Emad K. Alahmadi, Yahya A. Almutawif, Sari T. Alhuofie, Rana A. Alaeq, Areej A. Alhazmi, Mustafa A. Najim, Ahmed M. Hanafy
Polish Journal of Microbiology.2023; 72(4): 421. CrossRef
The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa
Prince Asare, Adwoa Asante-Poku, Stephen Osei-Wusu, Isaac Darko Otchere, Dorothy Yeboah-Manu
Frontiers in Public Health.2021;[Epub] CrossRef
Two target genes based multiple cross displacement amplification combined with a lateral flow biosensor for the detection of Mycobacterium tuberculosis complex
Junfei Huang, Ziyu Xiao, Xinggui Yang, Xu Chen, Xiaojuan Wang, Yijiang Chen, Wenlin Zheng, Wei Chen, Huijuan Chen, Shijun Li
BMC Microbiology.2021;[Epub] CrossRef
Duplex PCR for Detection of Aleutian Disease Virus from Biological and Environmental Samples
Marek Kowalczyk, Andrzej Jakubczak, Magdalena Gryzińska
Acta Veterinaria.2019; 69(4): 402. CrossRef

The assessment of host and bacterial proteins in sputum from active pulmonary tuberculosis: Hsin-Chih Lai , Yu-Tze Horng , Pen-Fang Yeh , Jann-Yuan Wang , Chin-Chung Shu , Jang-Jih Lu , Jen-Jyh Lee , Po-Chi Soo; J. Microbiol. 2016;54(11):761-767. Published online October 29, 2016; DOI: https://doi.org/10.1007/s12275-016-6201-x

47 View
0 Download
2 Crossref

Abstract

Pulmonary tuberculosis (TB) is caused by Mycobacterium tuberculosis. The protein composition of sputum may reflect the immune status of the lung. This study aimed to evaluate the protein profiles in spontaneous sputum samples from patients with active pulmonary TB. Sputum samples were collected from patients with pulmonary TB and healthy controls. Western blotting was used to analyze the amount of interleukin 10 (IL-10), interferon-gamma (IFN-γ), IL-25, IL- 17, perforin-1, urease, albumin, transferrin, lactoferrin, adenosine deaminase (also known as adenosine aminohydrolase, or ADA), ADA-2, granzyme B, granulysin, and caspase- 1 in sputum. Results of detection of IL-10, IFN-γ, perforin- 1, urease, ADA2, and caspase-1, showed relatively high specificity in distinguishing patients with TB from healthy controls, although sensitivities varied from 13.3% to 66.1%. By defining a positive result as the detection of any two proteins in sputum samples, combined use of transferrin and urease as markers increased sensitivity to 73.2% and specificity to 71.1%. Furthermore, we observed that the concentration of transferrin was proportional to the number of acidfast bacilli detected in sputum specimens. Detection of sputum transferrin and urease was highly associated with pulmonary TB infection. In addition, a high concentration of transferrin detected in sputum might correlate with active TB infection. This data on sputum proteins in patients with TB may aid in the development of biomarkers to assess the severity of pulmonary TB.

Citations

Citations to this article as recorded by

From simple to complex: Protein‐based biomarker discovery in tuberculosis
Zaynab Mousavian, Gunilla Källenius, Christopher Sundling
European Journal of Immunology.2023;[Epub] CrossRef
Interleukin 8 and Pentaxin (C-Reactive Protein) as Potential New Biomarkers of Bovine Tuberculosis
Xintao Gao, Xiaoyu Guo, Ming Li, Hong Jia, Weidong Lin, Lichun Fang, Yitong Jiang, Hongfei Zhu, Zhifang Zhang, Jiabo Ding, Ting Xin, Brad Fenwick
Journal of Clinical Microbiology.2019;[Epub] CrossRef

Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation: Elisabetta Iona , Manuela Pardini , Alessandro Mustazzolu , Giovanni Piccaro , Roberto Nisini , Lanfranco Fattorini , Federico Giannoni; J. Microbiol. 2016;54(8):565-572. Published online August 2, 2016; DOI: https://doi.org/10.1007/s12275-016-6150-4

48 View
0 Download
38 Crossref

Abstract

The physiology of dormant Mycobacterium tuberculosis was studied in detail by examining the gene expression of 51 genes using quantitative Reverse-Transcription Polymerase Chain Reaction. A forty-day period of dormancy in the Wayne culture model depicted four major transcription patterns. Some sigma factors and many metabolic genes were constant, whereas genes belonging to the dormancy regulon were activated on day 9. In particular, alpha-crystallin mRNA showed more than a 1,000-fold increase compared to replicating bacilli. Genes belonging to the enduring hypoxic response were up-regulated at day 16, notably, transcription factors sigma B and E. Early genes typical of log-phase bacilli, esat-6 and fbpB, were uniformly down-regulated during dormancy. Late stages of dormancy showed a drop in gene expression likely due to a lack of substrates in anaerobic respiration as demonstrated by the transcriptional activation observed following nitrates addition. Among genes involved in nitrate metabolism, narG was strongly up-regulated by nitrates addition. Dormant bacilli responded very rapidly when exposed to oxygen and fresh medium, showing a transcriptional activation of many genes, including resuscitation-promoting factors, within one hour. Our observations extend the current knowledge on dormant M. tuberculosis gene expression and its response to nutrients and to aerobic and anaerobic respiration.

Citations

Citations to this article as recorded by

Regulatory role of Mycobacterium tuberculosis MtrA on dormancy/resuscitation revealed by a novel target gene-mining strategy
Xiang Fu, Xiaoyu Wan, Aadil Ahmed Memon, Xiao-Yong Fan, Qiuhong Sun, Haifeng Chen, Yufeng Yao, Zixin Deng, Jian Ma, Wei Ma
Frontiers in Microbiology.2024;[Epub] CrossRef
Adaptation of the Mycobacterium tuberculosis transcriptome to biofilm growth
Madison A. Youngblom, Tracy M. Smith, Holly J. Murray, Caitlin S. Pepperell, Christopher M. Sassetti
PLOS Pathogens.2024; 20(4): e1012124. CrossRef
Identification of Rv1133c (MetE) as a marker of Mycobacterium tuberculosis replication and as a highly immunogenic antigen with potential immunodiagnostic power
Angelo Iacobino, Raffaela Teloni, Carmine Mancone, Francesco Facchiano, Alessandra Di Giamberardino, Cinzia Senatore, Antonio Di Virgilio, Alessio Lanni, Federico Giannoni, Roberto Nisini, Sabrina Mariotti
Frontiers in Immunology.2024;[Epub] CrossRef
Advances in understanding immune homeostasis in latent tuberculosis infection
Liangfei Niu, Hao Wang, Geyang Luo, Jing Zhou, Zhidong Hu, Bo Yan
WIREs Mechanisms of Disease.2024;[Epub] CrossRef
Microneedle patch-based enzyme-linked immunosorbent assay to quantify protein biomarkers of tuberculosis
Youngeun Kim, Mary Beth Lewis, Jihyun Hwang, Zheyu Wang, Rohit Gupta, Yuxiong Liu, Tuhina Gupta, James P. Barber, Srikanth Singamaneni, Fred Quinn, Mark R. Prausnitz
Biomedical Microdevices.2024;[Epub] CrossRef
Mycobacterium tuberculosis Adaptation in Response to Isoniazid Treatment in a Multi-Stress System That Mimics the Host Environment
Manita Yimcharoen, Sukanya Saikaew, Usanee Wattananandkul, Ponrut Phunpae, Sorasak Intorasoot, Chatchai Tayapiwatana, Bordin Butr-Indr
Antibiotics.2023; 12(5): 852. CrossRef
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, Federico Giannoni
Microorganisms.2023; 11(6): 1511. CrossRef
Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
Sam Afkhami, Michael R. D’Agostino, Maryam Vaseghi-Shanjani, Madeleine Lepard, Jack X. Yang, Rocky Lai, Margaret Wa Yan Choi, Alexis Chacon, Anna Zganiacz, Kees L. M. C. Franken, Hildegund C. Ertl, Tom H. M. Ottenhoff, Mangalakumari Jeyanathan, Amy Gillgr
npj Vaccines.2023;[Epub] CrossRef
WhiB4 Is Required for the Reactivation of Persistent Infection of Mycobacterium marinum in Zebrafish
Chen Lin, Yuting Tang, Yuchen Wang, Junli Zhang, Yeyu Li, Shuqin Xu, Bin Xia, Qiran Zhai, Yao Li, Lu Zhang, Jun Liu, Amit Singh
Microbiology Spectrum.2022;[Epub] CrossRef
Mycobacterium tuberculosis whiB3 and Lipid Metabolism Genes Are Regulated by Host Induced Oxidative Stress
Omar M. Barrientos, Elizabeth Langley, Yolanda González, Carlos Cabello, Martha Torres, Silvia Guzmán-Beltrán
Microorganisms.2022; 10(9): 1821. CrossRef
Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays
V. Dirix, N. Dauby, M. Hites, E. Watelet, A. Van Praet, A. Godefroid, E. Petit, M. Singh, C. Locht, F. Mascart, V. Corbière, Christine Y. Turenne
Journal of Clinical Microbiology.2022;[Epub] CrossRef
Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
Akanksha Verma, Antara Ghoshal, Ved Prakash Dwivedi, Ashima Bhaskar
Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef
Mycobacterial PPE36 Modulates Host Inflammation by Promoting E3 Ligase Smurf1-Mediated MyD88 Degradation
Zhangli Peng, Yan Yue, Sidong Xiong
Frontiers in Immunology.2022;[Epub] CrossRef
Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country
Violette Dirix, Philippe Collart, Anne Van Praet, Maya Hites, Nicolas Dauby, Sabine Allard, Judith Racapé, Mahavir Singh, Camille Locht, Françoise Mascart, Véronique Corbière
Frontiers in Immunology.2022;[Epub] CrossRef
The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment
Manita Yimcharoen, Sukanya Saikaew, Usanee Wattananandkul, Ponrut Phunpae, Sorasak Intorasoot, Watchara Kasinrerk, Chatchai Tayapiwatana, Bordin Butr-Indr
Infection and Drug Resistance.2022; Volume 15: 399. CrossRef
Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing M. tuberculosis?
RJH Hammond, Frank Kloprogge, O. Della Pasqua, Stephen H. Gillespie
Frontiers in Antibiotics.2022;[Epub] CrossRef
Strain-Specific Behavior of Mycobacterium tuberculosis in Interruption of Autophagy Pathway in Human Alveolar Type II Epithelial A549 Cells
Nasim Ebrahimifard, Shima Hadifar, Mansour Kargarpour Kamakoli, Ava Behrouzi, Sharareh Khanipour, Abolfazl Fateh, Seyed Davar Siadat, Farzam Vaziri
Iranian Biomedical Journal.2022; 26(4): 313. CrossRef
Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger
Elena G. Salina, Vadim Makarov
Microorganisms.2022; 10(12): 2334. CrossRef
Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium tuberculosis
Manikuntala Kundu, Joyoti Basu
Frontiers in Microbiology.2021;[Epub] CrossRef
Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis
M.A. Abo-Kadoum, Yongdong Dai, Mohammed Asaad, Insaf Hamdi, Jianping Xie
Microbial Drug Resistance.2021; 27(6): 768. CrossRef
Insights into the evolutionary history of the virulent factor HBHA of Mycobacterium tuberculosis
Mariana P. Lanfranconi, Ana Arabolaza, Hugo Gramajo, Héctor M. Alvarez
Archives of Microbiology.2021; 203(5): 2171. CrossRef
Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care
Darius Riziki Martin, Nicole Remaliah Sibuyi, Phumuzile Dube, Adewale Oluwaseun Fadaka, Ruben Cloete, Martin Onani, Abram Madimabe Madiehe, Mervin Meyer
Diagnostics.2021; 11(8): 1352. CrossRef
Transcriptome Changes of Mycobacterium marinum in the Process of Resuscitation From Hypoxia-Induced Dormancy
Jun Jiang, Chen Lin, Junli Zhang, Yuchen Wang, Lifang Shen, Kunpeng Yang, Wenxuan Xiao, Yao Li, Lu Zhang, Jun Liu
Frontiers in Genetics.2020;[Epub] CrossRef
Immunoinformatics Approach to Engineer a Potent Poly-epitope Fusion Protein Vaccine Against Coxiella burnetii
Ehsan Rashidian, Zeinab Shakarami Gandabeh, Ali Forouharmehr, Narges Nazifi, Nemat Shams, Amin Jaydari
International Journal of Peptide Research and Therapeutics.2020; 26(4): 2191. CrossRef
Coordinate regulation of virulence and metabolic genes by the transcription factor HbhR in Mycobacterium marinum
Dominique Raze, Jérôme Segers, Céline Mille, Stéphanie Slupek, Sophie Lecher, Loïc Coutte, Rudy Antoine, Lucie Ducrocq, Carine Rouanet, Ben J. Appelmelk, Camille Locht
Molecular Microbiology.2020; 113(1): 52. CrossRef
Small RNA Mcr11 requires the transcription factor AbmR for stable expression and regulates genes involved in the central metabolism of Mycobacterium tuberculosis
Roxie C. Girardin, Kathleen A. McDonough
Molecular Microbiology.2020; 113(2): 504. CrossRef
Resuscitation of Dormant “Non-culturable” Mycobacterium tuberculosis Is Characterized by Immediate Transcriptional Burst
Elena G. Salina, Artem S. Grigorov, Oksana S. Bychenko, Yulia V. Skvortsova, Ilgar Z. Mamedov, Tatyana L. Azhikina, Arseny S. Kaprelyants
Frontiers in Cellular and Infection Microbiology.2019;[Epub] CrossRef
Defining the Transcriptional and Post-transcriptional Landscapes of Mycobacterium smegmatis in Aerobic Growth and Hypoxia
M. Carla Martini, Ying Zhou, Huaming Sun, Scarlet S. Shell
Frontiers in Microbiology.2019;[Epub] CrossRef
Immunoscreening of the M. tuberculosis F15/LAM4/KZN secretome library against TB patients′ sera identifies unique active- and latent-TB specific biomarkers
Thamsanqa E. Chiliza, Manormoney Pillay, Kogieleum Naidoo, Balakrishna Pillay
Tuberculosis.2019; 115: 161. CrossRef
Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures
Yana R. Batyrshina, Yakov Sh Schwartz
Tuberculosis.2019; 117: 7. CrossRef
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH
Angelo Iacobino, Federico Giannoni, Manuela Pardini, Giovanni Piccaro, Lanfranco Fattorini
Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef
Bacteriophage gene products as potential antimicrobials against tuberculosis
Maria Puiu, Christina Julius
Biochemical Society Transactions.2019; 47(3): 847. CrossRef
The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection
Musa Marimani, Aijaz Ahmad, Adriano Duse
Tuberculosis.2018; 113: 200. CrossRef
Host-pathogen redox dynamics modulate Mycobacterium tuberculosis pathogenesis
Hayden T Pacl, Vineel P Reddy, Vikram Saini, Krishna C Chinta, Adrie J C Steyn
Pathogens and Disease.2018;[Epub] CrossRef
Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria
Dominique Raze, Claudie Verwaerde, Gaspard Deloison, Elisabeth Werkmeister, Baptiste Coupin, Marc Loyens, Priscille Brodin, Carine Rouanet, Camille Locht
Frontiers in Microbiology.2018;[Epub] CrossRef
Opening Pandora’s Box: Mechanisms of Mycobacterium tuberculosis Resuscitation
Ashley V. Veatch, Deepak Kaushal
Trends in Microbiology.2018; 26(2): 145. CrossRef
AbmR (Rv1265) is a novel transcription factor of Mycobacterium tuberculosis that regulates host cell association and expression of the non‐coding small RNA Mcr11
Roxie C. Girardin, Guangchun Bai, Jie He, Haixin Sui, Kathleen A. McDonough
Molecular Microbiology.2018; 110(5): 811. CrossRef
Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptation
Florence Levillain, Yannick Poquet, Ludovic Mallet, Serge Mazères, Michael Marceau, Roland Brosch, Franz-Christoph Bange, Philip Supply, Axel Magalon, Olivier Neyrolles, Marcel A. Behr
PLOS Pathogens.2017; 13(11): e1006752. CrossRef

Research Support, Non-U.S. Gov't

A small hairpin RNA targeting myeloid cell leukemia-1 enhances apoptosis in host macrophages infected with Mycobacterium tuberculosis: Fei-yu Wang , Yu-qing Zhang , Xin-min Wang , Chan Wang , Xiao-fang Wang , Jiang-dong Wu , Fang Wu , Wan-jiang Zhang , Le Zhang; J. Microbiol. 2016;54(4):330-337. Published online April 1, 2016; DOI: https://doi.org/10.1007/s12275-016-5627-5

53 View
0 Download
5 Crossref

Abstract

Myeloid cell leukemia-1 (Mcl-1) plays an important role in various cell survival pathways. Some studies indicated that the expression of Mcl-1 was upregulated in host cells during infection with the virulent Mycobacterium tuberculosis strain, H37Rv. The present study was designed to investigate the effect of inhibiting Mcl-1 expression both in vivo and in vitro on apoptosis of host macrophages infected with M. tuberculosis using a small hairpin (sh)RNA. Mcl-1 expression was detected by the real time-polymerase chain reaction, western blotting, and immunohistochemistry. Flow cytometry and transmission electron microscopy were used to measure host macrophage apoptosis. We found elevated Mcl-1 levels in host macrophages infected with M. tuberculosis H37Rv. The expression of Mcl-1 was downregulated efficiently in H37Rv-infected host macrophages using shRNA. Knockdown of Mcl-1 enhanced the extent of apoptosis in H37Rv-infected host macrophages significantly. The increased apoptosis correlated with a decrease in M. tuberculosis colony forming units recovered from H37Rv-infected cells that were treated with Mcl-1-shRNA. Reducing Mcl-1 accumulation by shRNA also reduced accumulation of the anti-apoptotic gene, Bcl-2, and increased expression of the pro-apoptotic gene, Bax, in H37Rv-infected host macrophages. Our results showed that specific knockdown of Mcl-1 expression increased apoptosis of host macrophages significantly and decreased the intracellular survival of a virulent strain of M. tuberculosis. These data indicate that interference with Mcl-1 expression may provide a new avenue for tuberculosis therapy.

Citations

Citations to this article as recorded by

Tolerance of Listeria monocytogenes to biocides used in food processing environments
Sanelisiwe Thinasonke Duze, Musa Marimani, Mrudula Patel
Food Microbiology.2021; 97: 103758. CrossRef
Regulatory role and mechanism of the inhibition of the Mcl-1 pathway during apoptosis and polarization of H37Rv-infected macrophages
Ling Han, Yang Lu, Xiaofang Wang, Shujun Zhang, Yingzi Wang, Fang Wu, Wanjiang Zhang, Xinmin Wang, Le Zhang
Medicine.2020; 99(42): e22438. CrossRef
Current and emerging therapies to combat persistent intracellular pathogens
Philip Arandjelovic, Marcel Doerflinger, Marc Pellegrini
Current Opinion in Pharmacology.2019; 48: 33. CrossRef
PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis
Eusondia Arnett, Ashlee M. Weaver, Kiersten C. Woodyard, Maria J. Montoya, Michael Li, Ky V. Hoang, Andrew Hayhurst, Abul K. Azad, Larry S. Schlesinger, Thomas R. Hawn
PLOS Pathogens.2018; 14(6): e1007100. CrossRef
Effect of gap junctions on RAW264.7 macrophages infected with H37Rv
Yang Lu, Xin-min Wang, Pu Yang, Ling Han, Ying-zi Wang, Zhi-hong Zheng, Fang Wu, Wan-jiang Zhang, Le Zhang
Medicine.2018; 97(35): e12125. CrossRef

Research Support, N.I.H., Extramural

The Mycobacterium tuberculosis relBE toxin:antitoxin genes are stress-responsive modules that regulate growth through translation inhibition: Shaleen B. Korch , Vandana Malhotra , Heidi Contreras , Josephine E. Clark-Curtiss; J. Microbiol. 2015;53(11):783-795. Published online October 28, 2015; DOI: https://doi.org/10.1007/s12275-015-5333-8

44 View
0 Download
39 Crossref

Abstract

Toxin-antitoxin (TA) genes are ubiquitous among bacteria and are associated with persistence and dormancy. Following exposure to unfavorable environmental stimuli, several species (Escherichia coli, Staphylococcus aureus, Myxococcus xanthus) employ toxin proteins such as RelE and MazF to downregulate growth or initiate cell death. Mycobacterium tuberculosis possesses three Rel TA modules (RelMtb): RelBEMtb, RelFGMtb and RelJKMtb (Rv1246c-Rv1247c, Rv2865-Rv2866, and Rv3357-Rv3358, respectively), which inhibit mycobacterial growth when the toxin gene (relE, relG, relK) is expressed independently of the antitoxin gene (relB, relF, relJ). In the present study, we examined the in vivo mechanism of the RelEMtb toxin protein, the impact of RelEMtb on M. tuberculosis physiology and the environmental conditions that regulate all three relMtb modules. RelEMtb negatively impacts growth and the structural integrity of the mycobacterial envelope, generating cells with aberrant forms that are prone to extensive aggregation. At a time coincident with growth defects, RelEMtb mediates mRNA degradation in vivo resulting in significant changes to the proteome. We establish that relMtb modules are stress responsive, as all three operons are transcriptionally activated following mycobacterial exposure to oxidative stress or nitrogen-limiting growth environments. Here we present evidence that the relMtb toxin:antitoxin family is stress-responsive and, through the degradation of mRNA, the RelEMtb toxin influences the growth, proteome and morphology of mycobacterial cells.

Citations

Citations to this article as recorded by

Bacterial persisters: molecular mechanisms and therapeutic development
Hongxia Niu, Jiaying Gu, Ying Zhang
Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef
Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
Yiduo Liu, Han Li, Dejia Dai, Jiakang He, Zhengmin Liang
Current Issues in Molecular Biology.2024; 46(6): 5825. CrossRef
Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants
Zian Zhang, Lifa Xu, Xiaochun Wang, LingYun Kong, Zilun Shi, Qiangsen Zhong, Yun Xu, Jianghong Wang
Tuberculosis.2024; 145: 102480. CrossRef
Enhancement of mycobacterial pathogenesis by host interferon-γ
Huynh Tan Hop, Pao-Chi Liao, Hsin-Yi Wu
Cellular and Molecular Life Sciences.2024;[Epub] CrossRef
Distribution of lineages and type II toxin-antitoxin systems among rifampin-resistant Mycobacterium Tuberculosis Isolates
Maryam Shafipour, Abdolmajid Mohammadzadeh, Pezhman Mahmoodi, Mahdi Dehghanpour, Ezzat Allah Ghaemi, Francesca Boldrin
PLOS ONE.2024; 19(10): e0309292. CrossRef
The zoonotic pathogen Wohlfahrtiimonas chitiniclastica – current findings from a clinical and genomic perspective
Anna Kopf, Boyke Bunk, Thomas Riedel, Percy Schröttner
BMC Microbiology.2024;[Epub] CrossRef
Genome wide screening to discover novel toxin–antitoxin modules in Mycobacterium indicus pranii; perspective on gene acquisition during mycobacterial evolution
Aayush Bahl, Roopshali Rakshit, Saurabh Pandey, Deeksha Tripathi
Biotechnology and Applied Biochemistry.2024;[Epub] CrossRef
PCR Development for Analysis of Some Type II Toxin–Antitoxin Systems, relJK, mazEF3, and vapBC3 Genes, in Mycobacterium tuberculosis and Mycobacterium bovis
Maryam Shafipour, Abdolmajid Mohammadzadeh, Ezzat Allah Ghaemi, Pezhman Mahmoodi
Current Microbiology.2024;[Epub] CrossRef
Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis
Satakshi Hazra, Risha Hazarika, Sanjukta Patra
Current Drug Targets.2023; 24(9): 751. CrossRef
Salidroside Attenuates Cisplatin-Induced Ototoxicity: An Experimental Study In Vitro and In Vivo
Kanglun Jiang, Tan Wang, Zirui Zhao, Lei Zhou, Huaili Jiang, Na Shen, Daquan Wu, Xinsheng Huang
Journal of Biomedical Nanotechnology.2023; 19(4): 600. CrossRef
The past, present and future of tuberculosis treatment
Kefan BI, Dan CAO, Cheng DING, Shuihua LU, Hongzhou LU, Guangyu ZHANG, Wenhong ZHANG, Liang LI, Kaijin XU, Lanjuan LI, Ying ZHANG
Journal of Zhejiang University (Medical Sciences).2022; 51(6): 657. CrossRef
Cellular functions of the ClpP protease impacting bacterial virulence
Mazen E. Aljghami, Marim M. Barghash, Emily Majaesic, Vaibhav Bhandari, Walid A. Houry
Frontiers in Molecular Biosciences.2022;[Epub] CrossRef
Comparative Genomic Analysis of the Human Pathogen Wohlfahrtiimonas Chitiniclastica Provides Insight Into the Identification of Antimicrobial Resistance Genotypes and Potential Virulence Traits
Anna Kopf, Boyke Bunk, Sina M. Coldewey, Florian Gunzer, Thomas Riedel, Percy Schröttner
Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef
Mycobacterium tuberculosis PknK Substrate Profiling Reveals Essential Transcription Terminator Protein Rho and Two-Component Response Regulators PrrA and MtrA as Novel Targets for Phosphorylation
Vandana Malhotra, Blessing P. Okon, Akash T. Satsangi, Sumana Das, Uchenna Watson Waturuocha, Atul Vashist, Josephine E. Clark-Curtiss, Deepak Kumar Saini, Amit Singh
Microbiology Spectrum.2022;[Epub] CrossRef
Transcriptional profiling of the stringent response mutant strain E. coli SR reveals enhanced robustness to large‐scale conditions
Martin Ziegler, Julia Zieringer, Ralf Takors
Microbial Biotechnology.2021; 14(3): 993. CrossRef
Persistence of Intracellular Bacterial Pathogens—With a Focus on the Metabolic Perspective
Wolfgang Eisenreich, Thomas Rudel, Jürgen Heesemann, Werner Goebel
Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
Laura Veschetti, Angela Sandri, Cristina Patuzzo, Paola Melotti, Giovanni Malerba, Maria M. Lleò
Microorganisms.2021; 9(1): 130. CrossRef
Genome‐wide interaction screen for Mycobacterium tuberculosis ClpCP protease reveals toxin–antitoxin systems as a major substrate class
Michal Ziemski, Julia Leodolter, Gabrielle Taylor, Anne Kerschenmeyer, Eilika Weber‐Ban
The FEBS Journal.2021; 288(1): 99. CrossRef
Evaluating the Potential for Cross-Interactions of Antitoxins in Type II TA Systems
Chih-Han Tu, Michelle Holt, Shengfeng Ruan, Christina Bourne
Toxins.2020; 12(6): 422. CrossRef
Targeting Type II Toxin–Antitoxin Systems as Antibacterial Strategies
Marcin Równicki, Robert Lasek, Joanna Trylska, Dariusz Bartosik
Toxins.2020; 12(9): 568. CrossRef
Persister cell development among Enterobacteriaceae, Pseudomonadaceae, Mycobacteriaceae and Staphylococcaceae biotypes: A review
Somanath Behera, Smaranika Pattnaik
Biocatalysis and Agricultural Biotechnology.2019; 22: 101401. CrossRef
Toxins targeting transfer RNAs: Translation inhibition by bacterial toxin–antitoxin systems
Lauren R. Walling, J. Scott Butler
WIREs RNA.2019;[Epub] CrossRef
The relevance of persisters in tuberculosis drug discovery
Soma Mandal, Samuel Njikan, Anuradha Kumar, Julie V. Early, Tanya Parish
Microbiology .2019; 165(5): 492. CrossRef
The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection
Dongzhu Ma, Jonathan B. Mandell, Niles P. Donegan, Ambrose L. Cheung, Wanyan Ma, Scott Rothenberger, Robert M. Q. Shanks, Anthony R. Richardson, Kenneth L. Urish, Jon P. Boyle
mBio.2019;[Epub] CrossRef
Toxin–antitoxin systems shows variability among Mycobacterium tuberculosis lineages
J S Solano-Gutierrez, C Pino, J Robledo
FEMS Microbiology Letters.2019;[Epub] CrossRef
Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people
Wing W. Yew, Takashi Yoshiyama, Chi C. Leung, Denise P. Chan
Respirology.2018; 23(6): 567. CrossRef
RE: “DIETARY INTAKE OF ANTIOXIDANT VITAMINS AND CAROTENOIDS AND RISK OF DEVELOPING ACTIVE TUBERCULOSIS IN A PROSPECTIVE POPULATION-BASED COHORT”
Wing Wai Yew, Denise P Chan, Chi Chiu Leung, Ying Zhang
American Journal of Epidemiology.2018; 187(7): 1570. CrossRef
System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis
Sakshi Agarwal, Prabhakar Tiwari, Amar Deep, Saqib Kidwai, Shamba Gupta, Krishan Gopal Thakur, Ramandeep Singh
The Journal of Infectious Diseases.2018; 217(11): 1809. CrossRef
Does oxidative stress contribute to adverse outcomes in HIV-associated TB?
Wing-Wai Yew, Denise P Chan, Amit Singhal, Ying Zhang, Shui-Shan Lee
Journal of Antimicrobial Chemotherapy.2018; 73(5): 1117. CrossRef
Co-expression network analysis of toxin-antitoxin loci in Mycobacterium tuberculosis reveals key modulators of cellular stress
Amita Gupta, Balaji Venkataraman, Madavan Vasudevan, Kiran Gopinath Bankar
Scientific Reports.2017;[Epub] CrossRef
The endobacterium of an arbuscular mycorrhizal fungus modulates the expression of its toxin–antitoxin systems during the life cycle of its host
Alessandra Salvioli di Fossalunga, Justine Lipuma, Francesco Venice, Laurence Dupont, Paola Bonfante
The ISME Journal.2017; 11(10): 2394. CrossRef
Oxidative stress and TB outcomes in patients with diabetes mellitus?
Wing Wai Yew, Chi Chiu Leung, Ying Zhang
Journal of Antimicrobial Chemotherapy.2017; 72(6): 1552. CrossRef
Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016
Arundhati Maitra, Tengku Karmila Kamil, Monisha Shaik, Cynthia Amaning Danquah, Alina Chrzastek, Sanjib Bhakta
Virulence.2017; 8(6): 1005. CrossRef
Identification of four type II toxin-antitoxin systems in Actinobacillus pleuropneumoniae
Chengkun Zheng, Xigong Zhao, Ting Zeng, Manman Cao, Jiali Xu, Guolin Shi, Jinquan Li, Huanchun Chen, Weicheng Bei
FEMS Microbiology Letters.2017;[Epub] CrossRef
Emerging drugs and drug targets against tuberculosis
Nzungize Lambert, Abualgasim Elgaili Abdalla, Xiangke Duan, Jianping Xie
Journal of Drug Targeting.2017; 25(4): 296. CrossRef
Wake me when it’s over – Bacterial toxin–antitoxin proteins and induced dormancy
Nathan P Coussens, Dayle A Daines
Experimental Biology and Medicine.2016; 241(12): 1332. CrossRef
Emerging Roles of Toxin-Antitoxin Modules in Bacterial Pathogenesis
Barbara Kędzierska, Finbarr Hayes
Molecules.2016; 21(6): 790. CrossRef
Phenotypic Heterogeneity in Mycobacterium tuberculosis
Neeraj Dhar, John McKinney, Giulia Manina, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
Microbiology Spectrum.2016;[Epub] CrossRef
tRNAs taking charge
Jonathan W. Cruz, Nancy A. Woychik, Peter Sebo
Pathogens and Disease.2016; 74(2): ftv117. CrossRef

Research Support, Non-U.S. Gov'ts

Performance of a real-time PCR assay for the rapid identification of Mycobacterium species: Hye-young Wang , Hyunjung Kim , Sunghyun Kim , Do-kyoon Kim , Sang-Nae Cho , Hyeyoung Lee; J. Microbiol. 2015;53(1):38-46. Published online January 4, 2015; DOI: https://doi.org/10.1007/s12275-015-4495-8

43 View
0 Download
18 Crossref

Abstract

Mycobacteria cause a variety of illnesses that differ in severity and public health implications. The differentiation of Mycobacterium tuberculosis (MTB) from nontuberculous mycobacteria (NTM) is of primary importance for infection control and choice of antimicrobial therapy. The diagnosis of diseases caused by NTM is difficult because NTM species are prevalent in the environment and because they have fastidious properties. In the present study, we evaluated 279 clinical isolates grown in liquid culture provided by The Catholic University of Korea, St. Vincent’s Hospital using real-time PCR based on mycobacterial rpoB gene sequences. The positive rate of real-time PCR assay accurately discriminated 100% (195/195) and 100% (84/84) between MTB and NTM species. Comparison of isolates identified using the MolecuTech REBA Myco-ID? and Real Myco-ID? were completely concordant except for two samples. Two cases that were identified as mixed infection (M. intracellulare-M. massiliense and M. avium-M. massiliense co-infection) by PCRREBA assay were only detected using M. abscessus-specific probes by Real Myco-ID?. Among a total of 84 cases, the most frequently identified NTM species were M. intracellulare (n=38, 45.2%), M. avium (n=18, 23.7%), M. massiliense (n=10, 13.2%), M. fortuitum (n=5, 6%), M. abscessus (n=3, 3.9%), M. gordonae (n=3, 3.9%), M. kansasii (n=2, 2.4%), M. mucogenicum (n=2, 2.4%), and M. chelonae (n= 1, 1.2%). Real Myco-ID? is an efficient tool for the rapid detection of NTM species as well as MTB and sensitive and specific and comparable to conventional methods.

Citations

Citations to this article as recorded by

Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens
Guocan Yu, Yanqin Shen, Liwei Yao, Xudong Xu
Infection and Drug Resistance.2024; Volume 17: 673. CrossRef
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations
Véronique Dartois, Tracey L. Bonfield, Jim P. Boyce, Charles L. Daley, Thomas Dick, Mercedes Gonzalez-Juarrero, Shashank Gupta, Igor Kramnik, Gyanu Lamichhane, Barbara E. Laughon, Nicola I. Lorè, Kenneth C. Malcolm, Kenneth N. Olivier, Katherine L. Tuggle
Tuberculosis.2024; 147: 102503. CrossRef
Durlobactam to boost the clinical utility of standard of care β-lactams against Mycobacterium abscessus lung disease
Dereje A. Negatu, Wassihun Wedajo Aragaw, Tewodros T. Gebresilase, Sindhuja Paruchuri, Firat Kaya, Sung Jae Shin, Peter Sander, Véronique Dartois, Thomas Dick, Jared A. Silverman
Antimicrobial Agents and Chemotherapy.2024;[Epub] CrossRef
Epidemiology and laboratory detection of non-tuberculous mycobacteria
Nuo Xu, Lihong Li, Shenghai Wu
Heliyon.2024; 10(15): e35311. CrossRef
Molecular identification of non-tuberculous mycobacterial species isolated from extrapulmonary samples using real-time PCR and rpoB sequence analysis
Mohammad Hashemzadeh, Aram Asarehzadegan Dezfuli, Azar Dokht Khosravi, Maryam Moradi Bandbal, Atousa Ghorbani, Mahtab Hamed, Soolmaz Khandan Dezfuli
AMB Express.2023;[Epub] CrossRef
TO ANALYZE THE TB-PCR POSITIVITY RATE USING REAL-TIME PCR FOR EARLY DETECTION OF TUBERCULOSIS
DEEPAK SAWANT, LOKHANDE CD, SHARMA RK, CHOUGULE RA
Asian Journal of Pharmaceutical and Clinical Research.2023; : 167. CrossRef
Factors Associated with the Performance of Direct PCR Detection of Mycobacteria in Clinical Specimens: Retrospective Real-world Data
Chang-Hun Park
Laboratory Medicine Online.2023; 13(3): 205. CrossRef
Evaluation of a new assay for nontuberculous mycobacteria species identification in diagnostic material and cultures
Tatiana Smirnova, Vera Ustinova, Sofya Andreevskaya, Elena Larionova, Ekaterina Kiseleva, Larisa Chernousova, Dmitry Varlamov, Dmitry Sochivko, Atadzhan Ergeshov
Tuberculosis.2021; 130: 102124. CrossRef
Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major Mycobacterium Species
Guohui Xiao, Xing He, Su Zhang, Yaya Liu, Zhihang Liang, Houming Liu, Juanjuan Zhang, Min Ou, Shuhao Cai, Wenjie Lai, Tianyu Zhang, Lili Ren, Guoliang Zhang, Yi-Wei Tang
Journal of Clinical Microbiology.2020;[Epub] CrossRef
Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens
Sunghwan Shin, In Young Yoo, Hyang Jin Shim, On Kyun Kang, Byung Woo Jhun, Won-Jung Koh, Hee Jae Huh, Nam Yong Lee
Annals of Laboratory Medicine.2020; 40(2): 169. CrossRef
Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates
Ellappan Kalaiarasan, Kalpana Thangavelu, Krishnakumariamma Krishnapriya, Muthaiah Muthuraj, Maria Jose, Noyal Mariya Joseph
Tuberculosis.2020; 125: 101988. CrossRef
Comparison of the Three Molecular Diagnostic Assays for Molecular Identification ofMycobacterium tuberculosisand Nontuberculous Mycobacteria Species in Sputum Samples
Jinyoung Bae, Sung-Bae Park, Ji-Hoi Kim, Mi Ran Kang, Kyung Eun Lee, Sunghyun Kim, Hyunwoo Jin
Biomedical Science Letters.2020; 26(3): 170. CrossRef
Rapid Identification of Clinically Relevant Mycobacterium Species by Multicolor Melting Curve Analysis
Ye Xu, Bin Liang, Chen Du, Xueshan Tian, Xingshan Cai, Yanjie Hou, Hui Li, Rongrong Zheng, Junlian Li, Yuqin Liu, Kaili Wang, Muhammad Ammar Athar, Yaoju Tan, Qingge Li, Melissa B. Miller
Journal of Clinical Microbiology.2019;[Epub] CrossRef
Mycobacterium abscessus Complex Cutaneous Infection
Ruben Porudominsky, Eduardo H. Gotuzzo
Current Tropical Medicine Reports.2018; 5(3): 170. CrossRef
The assessment of host and bacterial proteins in sputum from active pulmonary tuberculosis
Hsin-Chih Lai, Yu-Tze Horng, Pen-Fang Yeh, Jann-Yuan Wang, Chin-Chung Shu, Chia-Chen Lu, Jang-Jih Lu, Jen-Jyh Lee, Po-Chi Soo
Journal of Microbiology.2016; 54(11): 761. CrossRef
Efectos adversos de terapia inmunosupresora en paciente reumatológico: infección por micobacterias no tuberculosas
Jean Sebastian Hurtado Hurtado
Reumatología Clínica.2016; 12(2): 118. CrossRef
Adverse Effects of Immunosuppressive Therapy in Rheumatic Patients: Non-tuberculous Mycobacterial Infection
Jean Sebastian Hurtado Hurtado
Reumatología Clínica (English Edition).2016; 12(2): 118. CrossRef
Nontuberculous Mycobacterial Lung Disease Caused byMycobacterium shinjukuense: The First Reported Case in Korea
Seong Mi Moon, Su-Young Kim, Myung Jin Chung, Seung Heon Lee, Sung Jae Shin, Won-Jung Koh
Tuberculosis and Respiratory Diseases.2015; 78(4): 416. CrossRef

Phosphorylation Regulates Mycobacterial Proteasome: Tripti Anandan , Jaeil Han , Heather Baun , Seeta Nyayapathy , Jacob T. Brown , Rebekah L. Dial , Juan A. Moltalvo , Min-Seon Kim , Seung Hwan Yang , Donald R. Ronning , Robert N. Husson , Joowon Suh , Choong-Min Kang; J. Microbiol. 2014;52(9):743-754. Published online September 2, 2014; DOI: https://doi.org/10.1007/s12275-014-4416-2

50 View
0 Download
14 Crossref

Abstract

Mycobacterium tuberculosis possesses a proteasome system that is required for the microbe to resist elimination by the host immune system. Despite the importance of the proteasome in the pathogenesis of tuberculosis, the molecular mechanisms by which proteasome activity is controlled remain largely unknown. Here, we demonstrate that the α-subunit (PrcA) of the M. tuberculosis proteasome is phosphorylated by the PknB kinase at three threonine residues (T84, T202, and T178) in a sequential manner. Furthermore, the proteasome with phosphorylated PrcA enhances the degradation of Ino1, a known proteasomal substrate, suggesting that PknB regulates the proteolytic activity of the proteasome. Previous studies showed that depletion of the proteasome and the proteasome- associated proteins decreases resistance to reactive nitrogen intermediates (RNIs) but increases resistance to hydrogen peroxide (H2O2). Here we show that PknA phosphorylation of unprocessed proteasome β-subunit (pre-PrcB) and α-subunit reduces the assembly of the proteasome complex and thereby enhances the mycobacterial resistance to H2O2 and that H2O2 stress diminishes the formation of the proteasome complex in a PknA-dependent manner. These findings indicate that phosphorylation of the M. tuberculosis proteasome not only modulates proteolytic activity of the proteasome, but also affects the proteasome complex formation contributing to the survival of M. tuberculosis under oxidative stress conditions.

Citations

Citations to this article as recorded by

Phosphoproteome modulation by nucleoside diphosphate kinase affects photosynthesis & stress tolerance of Nostoc PCC 7120
Anurag Kirti, Hema Rajaram
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2025; 1873(1): 141054. CrossRef
Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
Yiduo Liu, Han Li, Dejia Dai, Jiakang He, Zhengmin Liang
Current Issues in Molecular Biology.2024; 46(6): 5825. CrossRef
Comprehensive essentiality analysis of the Mycobacterium kansasii genome by saturation transposon mutagenesis and deep sequencing
Keith Levendosky, Niklas Janisch, Luis E. N. Quadri, Sabine Ehrt
mBio.2023;[Epub] CrossRef
Nitrate-nitrite fate and oxygen sensing in dormant Mycobacterium tuberculosis: A bioinorganic approach highlighting the importance of transition metals
Eduardo H.S. Sousa, Marta S.P. Carepo, José J.G. Moura
Coordination Chemistry Reviews.2020; 423: 213476. CrossRef
The Mycobacterium tuberculosis Pup-proteasome system regulates nitrate metabolism through an essential protein quality control pathway
Samuel H. Becker, Jordan B. Jastrab, Avantika Dhabaria, Catherine T. Chaton, Jeffrey S. Rush, Konstantin V. Korotkov, Beatrix Ueberheide, K. Heran Darwin
Proceedings of the National Academy of Sciences.2019; 116(8): 3202. CrossRef
PknG supports mycobacterial adaptation in acidic environment
Ruchi Paroha, Rashmi Chourasia, Rajesh Mondal, Shivendra K. Chaurasiya
Molecular and Cellular Biochemistry.2018; 443(1-2): 69. CrossRef
Bacterial Proteasomes: Mechanistic and Functional Insights
Samuel H. Becker, K. Heran Darwin
Microbiology and Molecular Biology Reviews.2017;[Epub] CrossRef
How to control an intracellular proteolytic system: Coordinated regulatory switches in the mycobacterial Pup-proteasome system
Eyal Gur, Maayan Korman, Nir Hecht, Ofir Regev, Shai Schlussel, Nimrod Silberberg, Yifat Elharar
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2017; 1864(12): 2253. CrossRef
Epigenetic Phosphorylation Control of Mycobacterium tuberculosis Infection and Persistence
Melissa Richard-Greenblatt, Yossef Av-Gay, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
Microbiology Spectrum.2017;[Epub] CrossRef
Prokaryotic Ubiquitin-Like Protein and Its Ligase/Deligase Enyzmes
Cyrille L. Delley, Andreas U. Müller, Michal Ziemski, Eilika Weber-Ban
Journal of Molecular Biology.2017; 429(22): 3486. CrossRef
Phosphorylation Modulates Catalytic Activity of Mycobacterial Sirtuins
Ghanshyam S. Yadav, Sandeep K. Ravala, Neha Malhotra, Pradip K. Chakraborti
Frontiers in Microbiology.2016;[Epub] CrossRef
Pupylation-dependent and -independent proteasomal degradation in mycobacteria
Frank Imkamp, Michal Ziemski, Eilika Weber-Ban
Biomolecular Concepts.2015; 6(4): 285. CrossRef
Age-related changes in the proteostasis network in the brain of the naked mole-rat: Implications promoting healthy longevity
Judy C. Triplett, Antonella Tramutola, Aaron Swomley, Jessime Kirk, Kelly Grimes, Kaitilyn Lewis, Miranda Orr, Karl Rodriguez, Jian Cai, Jon B. Klein, Marzia Perluigi, Rochelle Buffenstein, D. Allan Butterfield
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2015; 1852(10): 2213. CrossRef
Bacterial Proteasome Activator Bpa (Rv3780) Is a Novel Ring-Shaped Interactor of the Mycobacterial Proteasome
Cyrille L. Delley, Juerg Laederach, Michal Ziemski, Marcel Bolten, Daniel Boehringer, Eilika Weber-Ban, Riccardo Manganelli
PLoS ONE.2014; 9(12): e114348. CrossRef

Characterization of a Novel Antigen of Mycobacterium tuberculosis K Strain and Its Use in Immunodiagnosis of Tuberculosis: Paul J. Park , Ah Reum Kim , Yangkyo P. Salch , Taeksun Song , Sung Jae Shin , Seung Jung Han , Sang-Nae Cho; J. Microbiol. 2014;52(10):871-878. Published online August 27, 2014; DOI: https://doi.org/10.1007/s12275-014-4235-5

46 View
0 Download
7 Crossref

Abstract

*For correspondence. (S.J. Han) E-mail: hansjung@yuhs.ac / (S.N. Cho) E-mail: raycho@yuhs.ac Paul J. Park, Ah Reum Kim, Yangkyo P. Salch, Taeksun Song, Sung Jae Shin, Seung Jung Han*, and Sang-Nae Cho* Department of Microbiology and Institute for Immunology and Immunological Diseases, Brain Korea 21 Plus Project for the Medical Sciences, Yonsei University College of Medicine, Seoul 120-752, Republic of Korea (Received Apr 16, 2014 / Revised Jul 14, 2014 / Accepted Jul 16, 2014) Journal of Microbiology (2014) Vol. 52, No. 10, pp. 871–878 Copyright 􎨰􀁇2014, The Microbiological Society of Korea DOI 10.1007/s12275-014-4235-5 Characterization of a Novel Antigen of Mycobacterium tuberculosis K strain and Its Use in Immunodiagnosis of Tuberculosis Mycobacterium tuberculosis-specific antigens would be of great value in developing immunodiagnostic tests for tuberculosis (TB), but regional differences in molecular types of the organism may result in antigenic variation, which in turn affects the outcome of the tests. For example, the Beijing strains of M. tuberculosis are prevalent in East Asia, and in particular, the K strain and related strains of the Beijing family, are most frequently isolated during school outbreaks of TB in South Korea. From comparison of genome sequences between M. tuberculosis K strain and the H37Rv strain, a non-Beijing type, we identified a K strain-specific gene, InsB, which has substantial homology with the ESAT-6-like proteins. This study was, therefore, initiated to characterize the InsB protein for its immunogenicity in mice and to confirm its expression in TB patients by detecting antibodies to the protein. The InsB gene was cloned from M. tuberculosis K strain and expressed in Escherichia coli. The recombinant InsB protein was used for immunization of mice. All mice showed strong antibody responses to the InsB protein, and splenocytes stimulated with InsB showed strong IFN-γ and IL-17 responses and a weak IL-2 response, all of which have been implicated in disease expression and used for the immunodiagnosis of TB. Serum samples from TB patients also showed significant antibody responses to the InsB protein as compared to healthy control samples. These results indicate that the InsB protein is an M. tuberculosis K-strain-specific antigen that could further improve the current immunodiagnostic
methods
, especially for the South Korean population.

Citations

Citations to this article as recorded by

Association between Mycobacterium tuberculosis genotype and diabetes mellitus/hypertension: a molecular study
Shengqiong Guo, Shiguang Lei, Prasit Palittapongarnpim, Edward McNeil, Angkana Chaiprasert, Jinlan Li, Huijuan Chen, Weizheng Ou, Komwit Surachat, Wan Qin, Siyu Zhang, Rujuan Luo, Virasakdi Chongsuvivatwong
BMC Infectious Diseases.2022;[Epub] CrossRef
Gradient association between pulmonary tuberculosis and diabetes mellitus among households with a tuberculosis case: a contact tracing-based study
Shengqiong Guo, Shiguang Lei, Jinlan Li, Ling Li, Huijuan Chen, Virasakdi Chongsuvivatwong
Scientific Reports.2022;[Epub] CrossRef
Diagnostic Potential of a PPE Protein Derived fromMycobacterium tuberculosisBeijing/K Strain
Ahreum Kim, Kwang Joo Park, Young Sun Kim, Sang-Nae Cho, Hazel M Dockrell, Yun-Gyoung Hur
Yonsei Medical Journal.2020; 61(9): 789. CrossRef
Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent Mycobacterium tuberculosis Beijing K Strain
Woo Sik Kim, Hongmin Kim, Kee Woong Kwon, Sang-Nae Cho, Sung Jae Shin
Frontiers in Microbiology.2019;[Epub] CrossRef
Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice
Ahreum Kim, Yun-Gyoung Hur, Sunwha Gu, Sang-Nae Cho, Helene F. Rosenberg
Clinical and Vaccine Immunology.2017;[Epub] CrossRef
Host immune responses to antigens derived from a predominant strain of Mycobacterium tuberculosis
Yun-Gyoung Hur, Wou Young Chung, Ahreum Kim, Young Sun Kim, Hyon-Suk Kim, Sun-Hee Jang, Yeun Kim, Hyeyoung Lee, Kwang Joo Park, Sang-Nae Cho
Journal of Infection.2016; 73(1): 54. CrossRef
Purification and characterization of a novel glycoprotein from Streptomyces sp. ZX01
Guoqiang Zhang, Lirong Han, Guifeng Zhang, Xing Zhang, Juntao Feng
International Journal of Biological Macromolecules.2015; 78: 195. CrossRef

Detection of Inhibitors of Phenotypically Drug-tolerant Mycobacterium tuberculosis Using an In Vitro Bactericidal Screen: Ian M. Bassett , Shichun Lun , William R. Bishai , Haidan Guo , Joanna R. Kirman , Mudassar Altaf , Ronan F. O’Toole; J. Microbiol. 2013;51(5):651-658. Published online June 25, 2013; DOI: https://doi.org/10.1007/s12275-013-3099-4

39 View
0 Download
10 Crossref

Abstract

Many whole cell screens of chemical libraries currently in use are based on inhibition of bacterial growth. The goal of this study was to develop a chemical library screening model that enabled detection of compounds that are active against drug-tolerant non-growing cultures of Mycobacterium tuberculosis. An in vitro model of low metabolically active mycobacteria was established with 8 and 30 day old cultures of M. smegmatis and M. tuberculosis, respectively. Reduction of resazurin was used as a measure of viability and the assay was applied in screens of chemical libraries for bactericidal compounds. The model provided cells that were phenotypically-resilient to killing by first and second-line clinical drugs including rifampicin. Screening against chemical libraries identified proteasome inhibitors, NSC310551 and NSC321206, and a structurally-related series of thiosemicarbazones, as having potent killing activity towards aged cultures. The inhibitors were confirmed as active against virulent M. tuberculosis strains including multi- and extensively-drug resistant clinical isolates. Our library screen enabled detection of compounds with a potent level of bactericidal activity towards phenotypically drug-tolerant cultures of M. tuberculosis.

Citations

Citations to this article as recorded by

Cytotoxicity and activity of thiosemicarbazones and semicarbazones in Mycobacterium tuberculosis: a systematic review
Ana Paula Desiree de Oliveira, Eloísa Gibin Sampiron, Jean Eduardo Meneguello, Andressa Lorena Ieque, Katiany Rizzieri Caleffi Ferracioli, Rosilene Fressatti Cardoso, Fábio Vandresen, Regiane Bertin de Lima Scodro
Cuadernos de Educación y Desarrollo.2024; 16(6): e4683. CrossRef
High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery
Navid J. Ayon
Metabolites.2023; 13(5): 625. CrossRef
Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery
Summaya Perveen, Rashmi Sharma
Biochemical Pharmacology.2022; 197: 114906. CrossRef
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Véronique A. Dartois, Eric J. Rubin
Nature Reviews Microbiology.2022; 20(11): 685. CrossRef
Identification of small molecules targeting homoserine acetyl transferase from Mycobacterium tuberculosis and Staphylococcus aureus
Deepika Chaudhary, Avantika Singh, Mardiana Marzuki, Abhirupa Ghosh, Saqib Kidwai, Tannu Priya Gosain, Kiran Chawla, Sonu Kumar Gupta, Nisheeth Agarwal, Sudipto Saha, Yashwant Kumar, Krishan Gopal Thakur, Amit Singhal, Ramandeep Singh
Scientific Reports.2022;[Epub] CrossRef
In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
Tanya Parish
Expert Opinion on Drug Discovery.2020; 15(3): 349. CrossRef
The relevance of persisters in tuberculosis drug discovery
Soma Mandal, Samuel Njikan, Anuradha Kumar, Julie V. Early, Tanya Parish
Microbiology .2019; 165(5): 492. CrossRef
Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products
Carolina Rodrigues Felix, Rashmi Gupta, Sandra Geden, Jill Roberts, Priscilla Winder, Shirley A. Pomponi, Maria Cristina Diaz, John K. Reed, Amy E. Wright, Kyle H. Rohde
Antimicrobial Agents and Chemotherapy.2017;[Epub] CrossRef
Targeting Phenotypically TolerantMycobacterium tuberculosis
Ben Gold, Carl Nathan, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
Microbiology Spectrum.2017;[Epub] CrossRef
Optimization and Evaluation of 5-Styryl-Oxathiazol-2-oneMycobacterium tuberculosisProteasome Inhibitors as Potential Antitubercular Agents
Francesco Russo, Johan Gising, Linda Åkerbladh, Annette K. Roos, Agata Naworyta, Sherry L. Mowbray, Anders Sokolowski, Ian Henderson, Torey Alling, Mai A. Bailey, Megan Files, Tanya Parish, Anders Karlén, Mats Larhed
ChemistryOpen.2015; 4(3): 342. CrossRef

First
Prev
Page of 2
Next
Last

Search